Literature DB >> 23195477

Anti-inflammatory activity of compound D {(E)-4-(3',4'-dimethoxyphenyl)but-3-en-2-ol} isolated from Zingiber cassumunar Roxb.

A Panthong1, D Kanjanapothi, W Niwatananant, P Tuntiwachwuttikul, V Reutrakul.   

Abstract

Compound D, (E)-4-(3',4'-dimethoxyphenyl)but-3-en-2-ol, is one of many compounds found in the hexane extract of Zingiber cassumunar Roxb. The anti-inflammatory activity of compound D was assessed using various inflammatory models in comparison with aspirin, indomethacin and prednisolone. The results obtained showed that the anti-inflammatory effect of compound D mediated prominently on the acute phase of inflammation. It exerted marked inhibition on carrageenin-induced rat paw edema as well as on the exudate formation, leukocyte accumulation and prostaglandin biosynthesis in carrageenin-induced rat pleurisy. Compound D possessed only slight inhibition on both primary and secondary lesions of adjuvant-induced arthritis and had no effect on cotton pellet-induced granuloma. Compound D elicited analgesic activity when tested on acetic acid-induced writhing response in mice but had weak inhibitory activity on tail flick responding to radiant heat. Compound D possessed marked antipyretic effect when tested on yeast-induced hyperthermia in rats.
Copyright © 1997 Gustav Fischer Verlag. Published by Elsevier GmbH.. All rights reserved.

Entities:  

Year:  1997        PMID: 23195477     DOI: 10.1016/S0944-7113(97)80069-4

Source DB:  PubMed          Journal:  Phytomedicine        ISSN: 0944-7113            Impact factor:   5.340


  6 in total

1.  Formulation, physicochemical characterization, and in vitro study of chitosan/HPMC blends-based herbal blended patches.

Authors:  Jirapornchai Suksaeree; Chaowalit Monton; Fameera Madaka; Tun Chusut; Worawan Saingam; Wiwat Pichayakorn; Prapaporn Boonme
Journal:  AAPS PharmSciTech       Date:  2014-09-19       Impact factor: 3.246

2.  Clinical Efficacy and Safety of Yellow Oil Formulations 3 and 4 versus Indomethacin Solution in Patients with Symptomatic Osteoarthritis of the Knee: A Randomized Controlled Trial.

Authors:  Nut Koonrungsesomboon; Supanimit Teekachunhatean; Sunee Chansakaow; Nutthiya Hanprasertpong
Journal:  Evid Based Complement Alternat Med       Date:  2020-07-25       Impact factor: 2.629

3.  Thai massage, and Thai herbal compress versus oral ibuprofen in symptomatic treatment of osteoarthritis of the knee: a randomized controlled trial.

Authors:  Natthakarn Chiranthanut; Nutthiya Hanprasertpong; Supanimit Teekachunhatean
Journal:  Biomed Res Int       Date:  2014-09-01       Impact factor: 3.411

4.  The Distinction of Hot Herbal Compress, Hot Compress, and Topical Diclofenac as Myofascial Pain Syndrome Treatment.

Authors:  Jurairat Boonruab; Netraya Nimpitakpong; Watchara Damjuti
Journal:  J Evid Based Integr Med       Date:  2018 Jan-Dec

Review 5.  Phytochemicals and Bioactivities of Zingiber cassumunar Roxb.

Authors:  Ah-Reum Han; Hyunyoung Kim; Donglan Piao; Chan-Hun Jung; Eun Kyoung Seo
Journal:  Molecules       Date:  2021-04-19       Impact factor: 4.411

6.  Safety Evaluation of Zingiber cassumunar Roxb. Rhizome Extract: Acute and Chronic Toxicity Studies in Rats.

Authors:  Sittichai Koontongkaew; Orapan Poachanukoon; Seewaboon Sireeratawong; Thaweephol Dechatiwongse Na Ayudhya; Parirat Khonsung; Kanjana Jaijoy; Ruedee Soawakontha; Monraudee Chanchai
Journal:  Int Sch Res Notices       Date:  2014-11-16
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.